NCT00828828 Antibody Response to Influenza Vaccine in Patients With Sarcoidosis Status COMPLETED Phase N/A
NCT00735020 Study to Evaluate Safety, Tolerability and Immunogenicity of a Bedside Mixing Combination of Two Adjuvanted Influenza Vaccines Status COMPLETED Phase PHASE1
NCT00607217 The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases Status COMPLETED Phase PHASE2/PHASE3
NCT00607178 The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases Status COMPLETED Phase PHASE2/PHASE3
NCT00596336 Study of Immune Responses to Influenza Vaccination With or Without Imiquimod Application in Untreated CLL Patients Status TERMINATED Phase PHASE2
NCT00466037 The Effect of Rituximab on the Humoral Response to Influenza Vaccine Status TERMINATED Phase NA
NCT00408395 Safety and Immunogenicity of 2 Commercially Available Influenza Vaccines in Children Status COMPLETED Phase PHASE2
NCT00316628 Safety and Immunogenicity of an Adjuvanted Influenza Vaccine in Subjects Aged 65 Years and Over. Status COMPLETED Phase PHASE2
NCT00316615 Safety and Immunogenicity of a Inactivated Influenza Vaccine When Administered to Non Elderly Adults and Elderly Subjects. Status COMPLETED Phase PHASE2
NCT00310648 Comparative Trial Evaluating Safety and Immunogenicity of an Adjuvanted and a Conventional Influenza Vaccine in Elderly Subjects (> 60 Years) Status COMPLETED Phase PHASE3
NCT00197223 Post-marketing Study to Evaluate the Efficacy of Influenza Vaccine Status COMPLETED Phase PHASE3